Fundz

Bio Protocol raises $6.9M to launch its AI-native decentralized science platform, ensuring faster biotech funding and drug discovery, led by Maelstrom Fund.

PRIVATESep 17, 2025

Amount Raised

$6.9 Million

Round Type

Funding Round

ZugBiotechnologyresearch

Investors

Maelstrom Fund

Description

Bio Protocol has raised $6.9 million in a funding round led by Maelstrom Fund, with contributions from notable biotech and crypto investors. This funding will support Bio Protocol's expansion into a comprehensive platform for AI-driven decentralized science and drug discovery. The platform aims to unite researchers, patients, and crypto users in accelerating scientific innovation. With new standards in funding and research capabilities, Bio Protocol seeks to revolutionize how biotech progresses from ideas to market-ready solutions.

Who else raised in research and Biotechnology around the same time

Companies in the same sectors as Bio Protocol that raised within 45 days of this round, from Fundz verified event records.

  • Plastomics raised $5.8M (Series B) on October 27, 2025.
  • Grail raised $325M (Post-IPO Equity) on October 20, 2025.
  • Faeth Therapeutics raised $25M (Funding Round) on October 20, 2025.
  • Cyclana Bio raised $6.7M (Pre-Seed) on October 20, 2025.
  • Adcytherix raised $122M (Series A) on October 16, 2025.
  • Bexorg raised $23M (Series A) on October 16, 2025.

Who to call at Bio Protocol, and when

A new round usually means Bio Protocol is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Bio Protocol raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Bio Protocol, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Bio Protocol. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Bio Protocol

Location

Zug, Zug, Switzerland

About

Bio Protocol is a decentralized science (DeSci) platform supporting the launch and growth of AI-driven biotech projects. By breaking down traditional barriers and introducing decentralized scientific funding, Bio accelerates drug discovery, reduces costs and makes biotech innovation more accessible to researchers and patients worldwide.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Bio Protocol raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contactsElliott, Head of Tech & InnovationSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Bio Protocol's next move

See what Strategic adds

Bio Protocol raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.